@article {Snider2021.04.20.21255798, author = {Samuel B Snider and Ibrahim Migdady and Sarah L LaRose and Morgan E Mckeown and Robert W Regenhardt and Pui Man Rosalind Lai and Henrikas Vaitkevicius and Rose Du}, title = {Vasospasm severity is associated with cerebral infarction after subarachnoid hemorrhage}, elocation-id = {2021.04.20.21255798}, year = {2021}, doi = {10.1101/2021.04.20.21255798}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background The presence of angiographic vasospasm after aneurysmal subarachnoid hemorrhage (aSAH) is associated with delayed-cerebral ischemia (DCI)-related cerebral infarction and worsened neurological outcome. Transcranial doppler (TCD) measurements of cerebral blood velocity are commonly used after aSAH to screen for vasospasm. We sought to determine whether time-varying TCD measured vasospasm severity is associated with cerebral infarction and to investigate the performance characteristics of different time/severity cutoffs for predicting cerebral infarction.Methods We used a retrospective, single-center cohort of consecutive adult aSAH patients with angiographic vasospasm and at least one TCD study. Our primary outcome was DCI-related cerebral infarction, defined as an infarction developing at least 2 days after any surgical intervention without an alternative cause. Time-varying TCD vasospasm severity was defined ordinally (absent, mild, moderate, severe) by the most abnormal vessel on each post-admission hospital day. Cox proportional-hazards models were used to examine associations between time-varying vasospasm severity and infarction. The optimal TCD-based time/severity thresholds for predicting infarction were then identified using the Youden J statistic.Results Of 218 aSAH patients with angiographic vasospasm, 27 (12\%) developed DCI-related infarction. As compared to those without infarction, patients with infarction had higher modified Fisher scale (mFS) scores, and an earlier onset of more-severe vasospasm. Adjusted for mFS, vasospasm severity was associated with infarction (aHR 1.9, 95\% CI: 1.3-2.6). A threshold of at least mild vasospasm severity on hospital day 4 had a negative predictive value of 92\% for the development of infarction, but a positive predictive value of 25\%.Conclusions In aSAH, TCD-measured vasospasm severity is associated with DCI-related infarction. In a single-center dataset, a TCD-based threshold for predicting infarction had a high negative predictive value, supporting its role as an early screening tool to identify at-risk patients.Competing Interest StatementSBS, IM, SLR, MEM, RWR, PMRL, and RD report no relevant disclosures. HV is employed by Marinus Pharmaceuticals.Funding StatementRWR was supported by an NIH R25 (R25 NS065743) grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Mass General Brigham IRB approved this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data available on reasonable request to the corresponding author.}, URL = {https://www.medrxiv.org/content/early/2021/04/23/2021.04.20.21255798}, eprint = {https://www.medrxiv.org/content/early/2021/04/23/2021.04.20.21255798.full.pdf}, journal = {medRxiv} }